Latest news
Loading news…
Neurimmune develops innovative immunotherapeutics for human diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
2
Monthly Visits
Available in Pro Contacts
26
Patents
19
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 33
- Active products
- 11
- Patents granted
- 19
- Trademarks
- 1
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $159K
Investor Activity
- Investments
- 2
- Lead investments
- 1
- Portfolio orgs
- 2
Company Info
- Org types
- company, investor
- HQ
- Schlieren, Zurich, Switzerland
Signals & Scores
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -1.1
Investments by Neurimmune Holding
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Neurimmune Holding
CSO
President & CEO
CFO
26
professional contacts at Neurimmune Holding
Contact execs at Neurimmune Holding →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Neurimmune Holding
Loading news…
FAQs about Neurimmune Holding
People who checked this page also checked these
Browse the full Acquirezy directory.